THE British Heart Foundation (BHF) has launched a new strategy that will see it capitalise on revolutionary areas of science and technology to reignite progress in preventing cardiovascular disease and saving lives.
The charity says that advances in areas such as artificial intelligence, data science, genomics, and technology offer a once-in-a-generation opportunity to transform the prevention, diagnosis, and treatment of many cardiovascular diseases.
Through its new strategy, the BHF seeks to grow the scope of its research to embrace the revolution in science and technology, nurture the next generation of cardiovascular researchers to secure a workforce fit for the future, and establish collaborations to tackle the biggest challenges in cardiovascular disease.
The strategy comes amid the worst start to a decade for heart health in 50 years. New BHF analysis shows that there has been a rise in the rate and number of deaths in working-age adults aged 20-64 from cardiovascular disease in the UK.
In 2023 the rate rose to 55 deaths per 100,000, from 49 per 100,000 in 2019 – the first sustained increase in at least a generation. Deaths in working-age adults rose by 18 per cent, from 18,693 in 2019, to 21,975 in 2023, averaging 420 a week.
The charity aims to help turn the tide by focusing its research funding in cutting-edge areas of science that can help to revolutionise how the UK prevents and treats cardiovascular disease.
Professor Bryan Williams, Chief Scientific and Medical Officer at the British Heart Foundation, said:
“We’re at a pivotal moment in the British Heart Foundation’s history. The number of people dying from cardiovascular disease has nearly halved since the BHF was established 64 years ago, with much of this incredible progress driven by our research. But these diseases remain one of the biggest, yet most preventable, causes of premature death and ill health in the UK. Our new strategy will see us go further than ever before to accelerate advances and take on the health challenges we face today.
“We’re living in an era of immense scientific and technological opportunity. Breakthroughs are occurring at a pace and scale that would have been unimaginable just a few years ago, while new technologies like gene editing and AI have completely changed what is possible for our BHF-funded scientists. We need to grasp this moment to stop the hard-won progress of recent decades from being lost for future generations.
“Through our new strategy, we will fund the brightest minds and best ideas and focus our investment in areas of research we think will have the greatest impact to unlock the lifesaving treatments and cures millions are still waiting for.”
By renewing its approach to funding research and innovation, the charity hopes to make progress towards achieving three ambitious goals set out in its new strategy. The BHF aims to:
- Help revolutionise heart disease prevention to stop more heart attacks and strokes before they strike.
- Discover groundbreaking treatments and cures that can save more lives from heart disease.
- Ensure people with heart disease get the information, care and support they need to help them live a longer, healthier life.
The charity is today urging governments, funders, and supporters to rally behind its mission.
As the UK’s biggest independent funder of cardiovascular research, the BHF will continue to fund research to advance understanding of all cardiovascular diseases, and develop the diagnostics, treatments and cures of the future.
Under the new strategy, the charity will also:
- Increase investment in research and innovation in emerging fields such as artificial intelligence, data science, behavioural sciences and engineering, and build capacity in these areas to develop a future-fit workforce.
- Initiate transformational partnerships with other funders, industry and patients to take on the biggest challenges in cardiovascular health and increase the UK’s investment in cardiovascular research.
- Launch a new series of Grand Challenges, offering awards of up to £10m, to make rapid advances in areas of unmet need or where there is significant opportunity.
- Increase its investment and support for the translation of research discoveries into new diagnostics and treatments that will benefit patients.
- Ensure that BHF-funded scientists and clinicians have the skills and tools required to guide discoveries into patient care, so they become the diagnostic tests and treatments of tomorrow.
- Enhance its support for piloting healthcare innovations with the potential to improve care for people living with cardiovascular disease.
Working in partnership will be a cornerstone of the new strategy, and key partnerships with the potential for transformational effects on cardiovascular research will be developed and strengthened.
This includes the MRC/BHF Centre of Research Excellence in Advanced Cardiac Therapies, which will receive up to £50 million investment from the Medical Research Council and the BHF over a maximum of 14 years to pioneer gene-therapy treatments to repair and regenerate damaged hearts.
On top of this, the BHF will focus on backing the UK’s cardiovascular research workforce, to grow the strength, breadth and diversity of the people powering the discoveries of the future. Funding schemes will be simplified whilst maintaining commitments to funding world leaders in cardiovascular science.
To complement its refreshed plans for research investment and make progress towards its goals, the BHF’s new strategy also sets out how it will grow the scale and scope of its healthcare innovation funding, make its information and support available to every family in need, grow the number of people trained in CPR and able to access a defibrillator, and influence governments and health services across the UK.
The new strategy can be read on the BHF website.




